| Q35675301 | Abdominal Aortic Diameter and the Risk for Asymptomatic Peripheral Arterial Disease in Patients with Type 2 Diabetes. |
| Q37631664 | Abdominal aortic aneurysms and coronary artery disease in a small country with high cardiovascular burden |
| Q39430450 | Association of high sensitivity C-reactive protein and abdominal aortic aneurysm: a meta-analysis and systematic review |
| Q57130161 | Characterization of aneurysmal aortas by biochemical, thermal, and dielectric techniques |
| Q89625609 | Circular RNA expression profile and its potential regulative role in human abdominal aortic aneurysm |
| Q33694487 | Extracellular matrix molecules: potential targets in pharmacotherapy. |
| Q37809741 | Pathophysiology and epidemiology of abdominal aortic aneurysms |
| Q34816002 | Periadventitial adipose-derived stem cell treatment halts elastase-induced abdominal aortic aneurysm progression |
| Q34727936 | Population risk factor estimates for abdominal aortic aneurysm from electronic medical records: a case control study |
| Q37600970 | Review of current theories for abdominal aortic aneurysm pathogenesis |
| Q37400367 | Risk factors in abdominal aortic aneurysm and in Polish population aortoiliac occlusive disease and differences between them [corrected]. |
| Q91673125 | Selective and marked decrease of complement receptor C5aR2 in human thoracic aortic aneurysms: a dysregulation with potential inflammatory effects |
| Q38956669 | Visceral adiposity is not associated with abdominal aortic aneurysm presence and growth |
Search more.